Articles
-
Sep 19, 2024 |
lupus.bmj.com | Yanjie Hao |Dylan Hansen |Worawit Louthrenoo |Yi-Hsing Chen
DiscussionAttainment of low disease activity in SLE is included in the updated EULAR recommendations for SLE as a treatment target.22 LLDAS is the most widely accepted and validated23–27 low disease activity end point for SLE. According to the definition of LLDAS, major organ system activity such as renal, central nervous system, cardiopulmonary, vasculitis, fever, haemolytic anaemia or gastrointestinal activity is excluded.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →